DHEA-S Levels and Cardiovascular Disease Mortality in Postmenopausal Women: Results from the National Institutes of Health—National Heart, Lung, and Blood Institute (NHLBI)-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) | Zendy

Chrisandra Shufelt | Zendy; Philip Bretsky | Zendy; Cristina Almeida | Zendy; B. Delia Johnson | Zendy; Leslee J. Shaw | Zendy; Ricardo Azziz | Zendy; Glenn D. Braunstein | Zendy; Carl J. Pepine | Zendy; Vera Bittner | Zendy; Diane A Vido | Zendy; Frank Z. Stanczyk | Zendy; C. Noel Bairey Merz | Zendy

Open Access

DHEA-S Levels and Cardiovascular Disease Mortality in Postmenopausal Women: Results from the National Institutes of Health—National Heart, Lung, and Blood Institute (NHLBI)-Sponsored Women’s Ischemia Syndrome Evaluation (WISE)

Author(s) -

Chrisandra Shufelt,

Philip Bretsky,

Cristina Almeida,

B. Delia Johnson,

Leslee J. Shaw,

Ricardo Azziz,

Glenn D. Braunstein,

Carl J. Pepine,

Vera Bittner,

Diane A Vido,

Frank Z. Stanczyk,

C. Noel Bairey Merz

Publication year - 2010

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2010-0143

Subject(s) - medicine , hazard ratio , myocardial infarction , cardiology , dehydroepiandrosterone sulfate , coronary artery disease , mortality rate , stroke (engine) , confidence interval , androgen , hormone , mechanical engineering , engineering

Dehydroepiandrosterone sulfate (DHEA-S), a major circulating sex steroid prohormone, declines with age. Low levels have been associated with increased cardiovascular disease (CVD) risk and all-cause mortality, although these results have not been consistently replicated, particularly in women.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research